Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab

Osteoporos Int. 2010 Nov;21(11):1963-4. doi: 10.1007/s00198-009-1145-1. Epub 2009 Dec 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents / adverse effects*
  • Bone Diseases, Metabolic / drug therapy*
  • Denosumab
  • Female
  • Humans
  • Opportunistic Infections / chemically induced*
  • Osteoporosis / drug therapy
  • RANK Ligand / adverse effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents
  • RANK Ligand
  • Denosumab